Clinical Trial Update: A Study of AMG 114 Administered by Subcutaneous Injection for the Treatment of Anemia in Subjects With Non-Myeloid Malignancies Receiving Multicycle Chemotherapy [Phase 1, Phase 2]

View source ↗

Summary

An early-phase (Phase 1/2) trial of AMG 114 for anemia in cancer patients was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia
• Cancer

Drugs mentioned

• AMG 114

Snippet

Sponsor: Amgen | Conditions: Anemia, Cancer | Phase 1, Phase 2 | Status: TERMINATED